Incruse ellipta 62.5 MCG INH 30S
Ended Awarded
- Contract number
- SPE2DB25FNLBR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,327
Award facts
- Contract value 100% obligated
- $3,326.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,326.57 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Incruse Ellipta 62.5 mcg inhalation medication in 30-unit packages, with completion scheduled for September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical support to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for the Defense Logistics Agency covering a broad spectrum of medications and medical supplies supporting military and veteran healthcare. The company's federal contract portfolio demonstrates consistent capability in competitively awarded pharmaceutical procurement across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Incruse Ellipta—a maintenance respiratory medication—exemplifies the routine pharmaceutical supply chain support AmerisourceBergen provides to the Defense Health Agency and other federal healthcare systems through its DLA prime vendor vehicle.
Quick answers
Who was awarded contract SPE2DB25FNLBR?
SPE2DB25FNLBR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FNLBR worth?
The government has obligated $3,327 on SPE2DB25FNLBR.
Is contract SPE2DB25FNLBR an order under another contract?
Yes. SPE2DB25FNLBR is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNLBR competed?
The extent of competition for SPE2DB25FNLBR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award